NCT04742855 is a clinical trial of Probiotics in Blepharitis, sponsored by University of Molise.

Who is sponsoring NCT04742855?

NCT04742855 is sponsored by University of Molise.

What drugs are being tested in NCT04742855?

Interventions in NCT04742855: Probiotics.

What condition does NCT04742855 study?

NCT04742855 studies Blepharitis.

Is NCT04742855 still recruiting?

NCT04742855 is currently status unknown. Last updated 8 February 2021.

Last reviewed 2021-02-08 · How we verify

NCT04742855

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Probiotics for Blepharitis in Adults and Children

Status unknown Last updated 8 February 2021

What this trial tests

trial testing Probiotics in Blepharitis in 45 participants. Status unknown.

Timeline

18 January 2021

Primary endpoint
18 January 2022

18 January 2022

Quick facts

Lead sponsor	University of Molise
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	45
Start date	18 January 2021
Primary completion	18 January 2022
Estimated completion	18 January 2022
Sites	1 location across Italy

Drugs / interventions tested

Probiotics — full drug profile →

Conditions studied

Blepharitis — all drugs for Blepharitis →

Sponsor

University of Molise

Who can join

Adults 8 to 80, any sex, with Blepharitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The alteration of the intestinal microbiota through the use of specific probiotics can improve the clinical course of blepharitis by restoring intestinal and immune homeostasis. The purpose of this study is to define the possible positive impact of probiotics on patients with blepharitis.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Clinical trials targeting the gut-microbiome to effect ocular health: a systematic review.
Russell MW, Muste JC, Kuo BL, Wu AK, et al · · 2023 · cited 5× · PMID 36918627 · DOI 10.1038/s41433-023-02462-7

Verify or expand the search:

Other trials of Probiotics

Trials testing the same drug.

NCT07470645 — Effects of Probiotic Supplementation on Stress and Anxiety in Students · NA · not yet recruiting
NCT06943235 — Study of Probiotics Combined With Concurrent Hyperfractionated ChemoRadiotherapy and Adebrelimab Immunomaintenance in th · Phase 2 · recruiting
NCT06827964 — Practice of Nutrition Package in Myanmar · NA · not yet recruiting
NCT06873165 — Development of Microbial Therapeutics for Metabolic-associated Fatty Liver Disease: From Mechanistic Investigations to C · NA · recruiting
NCT06583720 — Comparative Study Between Photodynamic Therapy with LED Associated with Probiotics in the Treatment of Halitosis · Phase 1 · recruiting

Other recruiting trials for Blepharitis

Currently open trials in the same condition.

NCT06371300 — Photobiomodulation With REd vs BluE Light (REBEL) · NA · recruiting
NCT06054217 — Effect of an Exploratory Vehicle on Meibomian Gland Dysfunction in Patients With Demodex · Phase 2 · active not recruiting
NCT04603222 — Evaluation of SUMMIT BRUSH in Treatment of Blepharitis · NA · recruiting

Other University of Molise trials

Trials by the same sponsor.

NCT06669598 — ENHANCING PHYSICAL and COGNITIVE EFFICIENCY in INDIVIDUALS AT RISK of DEMENTIA USING WHOLE-BODY ELECTROMYOSTIMULATION · NA · completed
NCT06690853 — Effects of Coordinative Warm-Up Exercise Protocols on the Technical and Cognitive Performance of Soccer Players · NA · completed
NCT06684808 — Impact of Active Breaks in Elementary School Children · NA · completed
NCT07116044 — Assessment of Response and Safety of Bulevirtide Treatment in Patients With Chronic Delta Virus Infection · completed
NCT04742829 — Effects of a Therapy With INTRAVIT® Tablets in Patients With Diabetic Retinopathy · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04742855 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Molise
Last refreshed: 8 February 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04742855.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing